Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3588]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
FDA approves pembrolizumab for adults and children with TMB-H solid tumours
FDA approves pembrolizumab for adults and children with TMB-H solid tumours
Researchers generate developmental map of human T-cells
Researchers generate developmental map of human T-cells
TERAVOLT registry tracks outcomes among thoracic cancer patients sickened by COVID-19
TERAVOLT registry tracks outcomes among thoracic cancer patients sickened by COVID-19
Cytokine implicated in HLH treatment resistance
Cytokine implicated in HLH treatment resistance
EHA 2020: Advances in treatment of high-risk chronic lymphocytic leukaemia
EHA 2020: Advances in treatment of high-risk chronic lymphocytic leukaemia
EHA 2020: A new treatment paradigm in relapsed refractory Hodgkin lymphoma
EHA 2020: A new treatment paradigm in relapsed refractory Hodgkin lymphoma
EHA 2020: Study of subcutaneous daratumumab shows improved clinical outcomes in the treatment of patients with amyloidosis
EHA 2020: Study of subcutaneous daratumumab shows improved clinical outcomes in the treatment of patients with...
EHA 2020: Ruxolitinib, the first proven drug for treating steroid-refractory acute graft-versus-host-disease
EHA 2020: Ruxolitinib, the first proven drug for treating steroid-refractory acute graft-versus-host-disease
Putting 'super' in natural killer cells
Putting 'super' in natural killer cells
FDA approves nivolumab for oesophageal squamous cell carcinoma
FDA approves nivolumab for oesophageal squamous cell carcinoma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation